Rituximab and Monitoring Strategies for Late Antibody-Mediated Rejection After Kidney Transplantation
BACKGROUND: There is limited information on treatment strategies and monitoring strategies for late antibody-mediated rejection (ABMR) after kidney transplantation. METHODS: In this observational and nonrandomized study, we compared 78 patients diagnosed with late ABMR (>3 months after transplant...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5828696/ https://www.ncbi.nlm.nih.gov/pubmed/29536028 http://dx.doi.org/10.1097/TXD.0000000000000746 |